AVDL — AVADEL PHARMACEUTICALS
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 1 家机构在其最新 13F 申报中持有 AVDL(AVADEL PHARMACEUTICALS),合计申报市值 $16,对应 1 股。按股数计算较上季度增持 0.0%(+0 股),申报市值环比上升 0.0%。持仓集中度较高:前五大持有人占申报市值的 100.0%,前十大的集中度为 100.0%。
与上一季度相比,1 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
AVADEL PHARMACEUTICALS(AVDL)的主要机构持有人包括 BlackRock Inc、RTW INVESTMENTS, LP、Vanguard Group,按 13F 申报市值在本页 363 家持有人中排名居前。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q2 2026 | 1 | 1 | $16 | +0.0% |
| Q1 2026 | 2 | 21 | $442 | +0.0% |
| Q4 2025 | 213 | 66.84M | $1.44B | -31.1% |
| Q3 2025 | 194 | 80.54M | $1.23B | -0.1% |
| Q2 2025 | 173 | 79.71M | $704.18M | +5.2% |
| Q1 2025 | 175 | 75.32M | $591.76M | +2.3% |
| Q4 2024 | 163 | 78.59M | $825.54M | +10.5% |
| Q3 2024 | 180 | 75.03M | $983.48M | +2.4% |
表内 8 个季度中,机构持股合计减少 100%(Q3 2024 → Q2 2026);单季变动最大的是 Q4 2025(-31.1%)。
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q1 2026 — 2 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 20 | $426 | 0.00% | 持有 | |
| 1 | $16 | 0.00% | 持有 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 7.04M | $151.74M | 0.00% | 增持 | |
| 5.86M | $126.39M | 0.00% | 增持 | |
| 4.52M | $97.30M | 1.55% | 新进 | |
| 3.86M | $83.16M | 4.48% | 新进 | |
| 2.82M | $60.83M | 0.05% | 新进 | |
| 2.68M | $57.84M | 3.74% | 持有 | |
| 2.28M | $49.10M | 0.00% | 减持 | |
| 2.16M | $46.48M | 0.00% | 减持 | |
| 2.05M | $44.15M | 2.16% | 新进 | |
| 1.89M | $40.77M | 12.75% | 减持 | |
| 1.82M | $39.30M | 0.02% | 减持 | |
| 1.68M | $36.29M | 0.33% | 新进 | |
| 1.29M | $27.87M | 0.24% | 增持 | |
| 1.19M | $25.73M | 0.55% | 减持 | |
| 1.13M | $24.38M | 0.43% | 减持 | |
| 1.09M | $23.43M | 2.99% | 新进 | |
| 855.86K | $18.44M | 6.51% | 减持 | |
| 797.20K | $17.18M | 0.00% | 减持 | |
| 793.75K | $17.11M | 0.00% | 减持 | |
| 793.75K | $17.11M | 0.00% | 减持 | |
| 782.24K | $16.86M | 0.13% | 增持 | |
| 702.07K | $15.13M | 0.06% | 减持 | |
| 684.32K | $14.75M | 0.01% | 减持 | |
| 655.06K | $14.12M | 0.01% | 增持 | |
| 607.27K | $13.09M | 0.00% | 增持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 7.43M | $113.43M | 0.05% | 减持 | |
| 6.97M | $106.49M | 0.00% | 增持 | |
| 5.61M | $85.61M | 0.00% | 增持 | |
| 5.44M | $83.14M | 0.67% | 减持 | |
| 5.37M | $81.99M | 1.50% | 减持 | |
| 5.31M | $81.16M | 1.49% | 增持 | |
| 4.00M | $61.07M | 0.32% | 持有 | |
| 2.68M | $40.99M | 3.30% | 持有 | |
| 2.29M | $35.01M | 0.00% | 增持 | |
| 2.29M | $34.95M | 11.24% | 减持 | |
| 2.26M | $34.49M | 0.00% | 增持 | |
| 2.18M | $33.23M | 0.00% | 持有 | |
| 2.10M | $32.03M | 1.23% | 持有 | |
| 1.63M | $24.84M | 0.55% | 增持 | |
| 1.34M | $20.44M | 0.00% | 增持 | |
| 955.86K | $14.60M | 6.22% | 持有 | |
| 897.09K | $13.70M | 0.06% | 持有 | |
| 856.84K | $13.08M | 0.00% | 增持 | |
| 799.48K | $12.21M | 0.00% | 增持 | |
| 799.48K | $12.21M | 0.00% | 增持 | |
| 754.38K | $11.52M | 0.00% | 增持 | |
| 750.00K | $11.45M | 0.10% | 新进 | |
| 724.86K | $11.07M | 2.54% | 减持 | |
| 688.99K | $10.52M | 0.01% | 增持 | |
| 677.98K | $10.35M | 0.01% | 减持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 11.13M | $98.49M | 0.05% | 减持 | |
| 6.80M | $60.21M | 0.00% | 增持 | |
| 6.49M | $57.42M | 0.52% | 增持 | |
| 6.16M | $54.47M | 1.01% | 增持 | |
| 5.56M | $49.24M | 0.00% | 增持 | |
| 5.18M | $45.81M | 1.22% | 减持 | |
| 4.00M | $35.39M | 0.19% | 减持 | |
| 2.68M | $23.75M | 2.43% | 持有 | |
| 2.35M | $20.84M | 7.80% | 减持 | |
| 2.17M | $19.20M | 0.00% | 增持 | |
| 2.10M | $18.56M | 0.94% | 持有 | |
| 2.07M | $18.33M | 0.00% | 增持 | |
| 1.19M | $10.55M | 0.00% | 增持 | |
| 1.01M | $8.98M | 2.73% | 新进 | |
| 981.27K | $8.68M | 0.21% | 增持 | |
| 958.88K | $8.49M | 4.49% | 增持 | |
| 897.09K | $7.94M | 0.04% | 持有 | |
| 875.24K | $7.75M | 0.01% | 减持 | |
| 839.12K | $7.43M | 0.00% | 增持 | |
| 802.99K | $7.11M | 0.40% | 增持 | |
| 786.45K | $6.96M | 0.00% | 增持 | |
| 786.45K | $6.96M | 0.00% | 增持 | |
| 748.88K | $6.63M | 0.00% | 增持 | |
| 703.28K | $6.22M | 0.00% | 增持 | |
| 678.12K | $6.00M | 0.01% | 持有 |
Q1 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 13.59M | $108.84M | 0.06% | 减持 | |
| 6.13M | $47.98M | 2.07% | 减持 | |
| 5.67M | $44.37M | 0.45% | 增持 | |
| 5.45M | $42.70M | 0.00% | 持有 | |
| 4.95M | $38.73M | 1.30% | 增持 | |
| 4.36M | $34.11M | 0.23% | 减持 | |
| 3.90M | $30.57M | 0.00% | 减持 | |
| 2.68M | $21.02M | 2.78% | 持有 | |
| 2.37M | $18.55M | 7.79% | 增持 | |
| 2.10M | $16.42M | 0.91% | 增持 | |
| 1.66M | $12.99M | 0.00% | 减持 | |
| 1.29M | $10.14M | 0.01% | 减持 | |
| 1.19M | $9.31M | 0.00% | 增持 | |
| 1.12M | $8.75M | 0.00% | 增持 | |
| 1.03M | $8.10M | 0.00% | 减持 | |
| 967.53K | $7.58M | 1.35% | 持有 | |
| 950.00K | $7.44M | 4.11% | 新进 | |
| 896.86K | $7.02M | 0.05% | 增持 | |
| 754.04K | $5.90M | 0.14% | 减持 | |
| 727.87K | $5.70M | 0.00% | 减持 | |
| 676.63K | $5.30M | 0.00% | 增持 | |
| 639.87K | $5.01M | 0.00% | 减持 | |
| 600.00K | $4.70M | 3.06% | 持有 | |
| 558.98K | $4.38M | 0.06% | 减持 | |
| 517.94K | $4.06M | 0.00% | 新进 |
新建仓(Q2 2026)
本季度没有基金新建该仓位。
完全清仓(较上季)
- IFP Advisors, Inc 卖出 20 股 · $426
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | — | — | — | — | — | — | — | — |
| ALLIANCEBERNSTEIN L.P. | — | — | 98.44K | 66.66K | 97.04K | 83.14K | 96.71K | 65.12K | 101.22K | — | — | — | — | — | — | — | — | — | — | — |
| Janus Henderson Group | — | — | 1.82M | 7.43M | 11.13M | 13.59M | 14.08M | 13.33M | 13.30M | 12.92M | 11.13M | 10.64M | — | — | — | — | — | — | — | — |
| BlackRock Inc | — | — | 7.04M | 6.97M | 6.80M | 5.45M | 5.44M | 5.26M | — | — | — | — | — | — | — | — | — | — | — | — |
| RTW INVESTMENTS, LP | — | — | — | — | — | — | — | — | — | 8.80M | 6.95M | 7.14M | — | — | — | — | — | — | — | — |
| Vanguard Group | — | — | 5.86M | 5.61M | 5.56M | 3.90M | 3.95M | 3.86M | 3.69M | — | — | — | — | — | — | — | — | — | — | — |
| Polar Capital Holdings Plc | — | — | — | 4.00M | 4.00M | 4.36M | 4.41M | 4.83M | 6.56M | 6.75M | 6.75M | 4.51M | — | — | — | — | — | — | — | — |
| Weiss Asset Management LP | — | — | 4.52M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| GENDELL JEFFREY L | — | — | 1.13M | 5.31M | 5.18M | 6.13M | 6.33M | 5.81M | 5.74M | 5.71M | 5.62M | 5.62M | — | — | — | — | — | — | — | — |
| TIG Advisors, LLC | — | — | 3.86M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BRANDES INVESTMENT PARTNERS, LP | — | — | 218.43K | 5.44M | 6.49M | 5.67M | 2.17M | 1.37M | 1.48M | 1.46M | 1.53M | 1.45M | — | — | — | — | — | — | — | — |
| Two Seas Capital LP | — | — | — | 5.37M | 6.16M | 4.95M | 4.30M | 2.25M | 2.12M | 318.24K | — | — | — | — | — | — | — | — | — | — |
| Vivo Capital, LLC | — | — | 2.68M | 2.68M | 2.68M | 2.68M | 2.68M | 2.68M | 3.97M | 3.97M | 4.10M | 4.10M | — | — | — | — | — | — | — | — |
| Fidelity International (FIL) | — | — | 2.82M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | — | — | 2.28M | 2.29M | 2.07M | 1.66M | 1.69M | 1.62M | 1.14M | 36.84K | 42.11K | 30.31K | — | — | — | — | — | — | — | — |
| Geode Capital Management | — | — | 2.16M | 2.18M | 2.17M | 1.19M | 1.17M | 1.15M | 1.16M | 104.23K | 92.58K | 94.41K | — | — | 79.08K | — | — | — | — | — |
| BRAIDWELL LP | — | — | — | — | — | — | 4.11M | 3.39M | 2.90M | 2.67M | — | — | — | — | — | — | — | — | — | — |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | — | — | 2.05M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| WEALTH EFFECTS LLC | — | — | 1.89M | 2.29M | 2.35M | 2.37M | 2.34M | 2.23M | 2.27M | 2.26M | 2.42M | 2.41M | — | — | — | — | — | — | — | — |
| Pentwater Capital Management LP | — | — | 1.68M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
常见问题
Which funds hold AVDL?
As of 2026-Q2, 1 institutional funds reported holding AVDL (AVADEL PHARMACEUTICALS) in SEC 13F filings, with a combined reported value of $16.
How many shares of AVDL do institutions own?
13F filers reported 1 shares of AVDL, worth $16 in aggregate at the end of 2026-Q2.
Is institutional ownership of AVDL rising or falling?
Share counts moved +0.0% versus the prior quarter — accumulation.
Who are the top institutional holders of AVDL?
The largest 13F holders are BlackRock Inc, RTW INVESTMENTS, LP, Vanguard Group, Weiss Asset Management LP, TIG Advisors, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of AVADEL PHARMACEUTICALS?
The major shareholders of AVADEL PHARMACEUTICALS (AVDL) by reported 13F value are BlackRock Inc, RTW INVESTMENTS, LP, Vanguard Group, Weiss Asset Management LP, TIG Advisors, LLC, among 363 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.